Italy Pet Veterinary Diets Market Size and Share

Italy Pet Veterinary Diets Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Italy Pet Veterinary Diets Market Analysis by Mordor Intelligence

The Italy Pet Veterinary Diets Market size is estimated to increase from USD 530 million in 2025 to USD 560 million in 2026 and reach USD 750 million by 2031, growing at a CAGR of 6% over 2026-2031. Therapeutic and specialist nutrition is capturing a growing share of total pet spending as pet owners increasingly prioritize products addressing digestive health, renal care, dermatology, mobility, and healthy aging. Italy's pet food and pet care market reached EUR 5.3 billion (USD 5.7 billion) in 2025, indicating a substantial consumer base for the continued growth of therapeutic feeding. The Italy pet veterinary diets market is further supported by stronger veterinary engagement, an aging pet population, and a rising trend among owners to view nutrition as an integral part of routine health management rather than just basic feeding. Colgate-Palmolive Company (Hill’s Pet Nutrition Inc.) reported a 23% increase in clinic-dispensed products in 2024, highlighting that veterinary recommendations remain the primary channel for adopting structured diets. Companies are responding with microbiome-focused product lines and digital tools to improve owner education, support refill adherence, and maintain the premium positioning of veterinary diet products in Italy's broader pet care market.

Key Report Takeaways

  • By sub product, Diabetes was the largest segment with a market share of 19.2% in 2025, while digestive senstivity was the fastest-growing segment with 10.0% CAGR through 2031.
  • By pets, dogs held 56.0% of the Italy pet veterinary diets market share in 2025, while dogs are forecast to expand at a 6.8% CAGR through 2031.
  • By distribution channel, Supermarkets/Hypermarkets accounted for 30.6% of the Italy pet veterinary diets market size in 2025, while the Online Channel is projected to grow at a 6.5% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Sub Product: Digestive Sensitivity Leads Growth Across Therapeutic Conditions

Diabetes represents the largest individual therapeutic diet category with a market share of 19.2% in the Italy pet veterinary diets market in 2025. At VMX 2026, Royal Canin previewed a new therapeutic formulation for overweight diabetic cats, highlighting the link between diabetes management and safe weight reduction. Renal diets remain the second-largest sub-product category, as chronic kidney disease affects over 30% of cats aged 10 years or older. Dechra's January 2026 European launch of SPECIFIC Kidney Support Hydrolyzed reflects continued investment in this area. Other therapeutic diets, including those for urinary tract disease, obesity, dermatological conditions, oral care, and related indications, complete the product portfolio. These offerings reflect the Italy pet veterinary diets market's focus on long-term, indication-specific feeding rather than discretionary premium purchases.

Digestive sensitivity is the fastest-growing product in the Italy pet veterinary diets market, with the segment projected to grow at a 10.0% CAGR from 2026 to 2031. This growth reflects increased awareness of food-responsive digestive disorders and the introduction of clinically focused products that extend beyond general wellness claims. In February 2025, Virbac launched Veterinary HPM Digestive Support wet diets for both dogs and cats, using species-specific nutritional designs rather than a generalized approach[3]Source: Virbac S.A., “Virbac Veterinary HPM Digestive Support Wet Diets Launch,” Virbac, virbac.com .This development highlights the shift in digestive care within the Italy pet veterinary diets market toward microbiome-focused and clinically validated solutions.

Italy Pet Veterinary Diets Market Share by Sub Product, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Italy Pet Veterinary Diets Market Share by Sub Product, 2025

By Pets: Dogs Drive Prescribed Volume, Cats Sustain Renal and Urinary Segments

Dogs represent the largest pet segment in the Italy pet veterinary diets market, accounting for a 56% market share in 2025. This dominance is driven by higher therapeutic spending per dog, extended treatment protocols for conditions such as obesity and digestive care, and stronger owner adherence to structured feeding plans. In March 2026, Royal Canin strengthened its focus on canine therapeutic diets by renewing its partnership with the University of Tennessee Veterinary Obesity Center, aligning product development with chronic condition research to provide improved products globally, including Italy.

Dogs are also the fastest-growing segment in the Italy pet veterinary diets market, with a projected compound annual growth rate (CAGR) of 6.8% from 2026 to 2031. This growth is supported by an increasing prevalence of lifestyle-related conditions such as diabetes, digestive sensitivity, and obesity-related complications, coupled with rising owner commitment to long-term prescribed feeding plans. Meanwhile, cats remain the primary segment for renal and urinary therapeutic demand due to the prevalence of chronic kidney disease and feline lower urinary tract disorders in older cats, which often require extended nutritional management. This gives cats a stable and high-value role in the market, even though they do not lead in total therapeutic revenue. Other pets continue to play a marginal role in the Italy pet veterinary diets market due to limited prescription formats and less structured purchasing behavior.

By Distribution Channel: Supermarkets Leads Volume, Online Channel helps in Growth of Therapeutic Diets

Supermarkets/Hypermarkets accounted for 30.6% of the Italy pet veterinary diets market share in 2025, making them the largest distribution channel. This dominance is attributed to routine household traffic, extensive brand visibility, and efforts by major suppliers to expand specialist shelf space near mainstream pet food. However, purchasing behavior in these outlets is primarily driven by diagnosis and refill needs rather than impulse buying. This results in more stable therapeutic demand compared to standard packaged pet food. Specialty stores also play a significant role, as they provide a better advisory environment for explaining prescribed nutrition choices. Physical retail continues to represent a substantial portion of the Italy pet veterinary diets market, though different channels serve the category in varying ways.

The online channel is the fastest-growing segment in the Italy pet veterinary diets market, projected to grow at a 6.5% CAGR from 2026 to 2031. Since prescribed diets often remain unchanged for extended periods, digital replenishment is particularly effective and fosters stronger customer retention compared to pet food. For instance, Dechra’s March 2025 launch of SPECIFIC in Italy began with a clinic-first rollout before expanding to broader distribution channels, highlighting the importance of veterinary credibility in building trust before scaling. Convenience stores and smaller outlets play a limited role, primarily serving as top-up options, as prescription-led nutrition requires a broader range and more specialized guidance than these formats typically offer.

Italy Pet Veterinary Diets Market Share by Distribution Channel, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Geography Analysis

Northern Italy accounts for the largest share of demand in the Italy pet veterinary diets market, driven by regions such as Lombardy, Emilia-Romagna, and Veneto. This area benefits from higher disposable incomes, a denser network of specialist veterinarians, and a well-developed specialty retail infrastructure. In May 2024, Mars, Incorporated enhanced its presence by opening the first One Mars, Incorporated's Office in Milan, integrating Royal Canin and AniCura operations to support a more cohesive pet care model in Italy's most affluent pet market. 

Central Italy represents the second-largest geographic segment in the Italy pet veterinary diets market, with Rome and the Tuscany corridor serving as key demand centers. Rome's large urban pet-owning population and growing specialty retail presence drive demand, while Tuscany demonstrates a preference for premium, functional products, favoring brands with health-focused credentials and Italian production. Monge & C. S.p.a.'s participation in the World Dog Show in Bologna and its nutrition-focused professional outreach in 2026 highlight ongoing efforts to build awareness through veterinarian-focused channels in central-northern Italy. Although specialist density is lower than in Milan or Bologna, the region continues to generate steady demand due to favorable awareness and purchasing power.

Southern Italy and the islands face significant constraints in the Italy pet veterinary diets market. Regions such as Campania, Sicily, Calabria, and Sardinia have notably lower densities of specialist veterinarians, which limits the initiation of prescriptions. The adoption gap in these areas is more closely linked to healthcare access challenges rather than a lack of owner interest in pet health products. Epidemiological reporting from April 2025 highlighted ongoing disparities in healthcare surveillance across central-southern and insular regions, emphasizing this structural issue. However, in the short term, advantages in distribution and diagnosis continue to concentrate most market value in northern and central Italy.

Competitive Landscape

The Italian pet veterinary diets market is moderately concentrated in 2025, with the top five players being Nestle S.A. (Purina), Mars, Incorporated, Farmina Pet Food, Colgate-Palmolive Company (Hill's Pet Nutrition Inc.), and Monge. Nestle S.A., through Purina PetCare, and Mars, Incorporated, through Royal Canin, maintain strong global positions due to their established veterinary science infrastructure and robust relationships with clinicians. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)’s Prescription Diet secures a competitive position by emphasizing prescription-focused products and maintaining clear channel separation from general over-the-counter nutrition. Farmina Pet Food, Monge & C.s.p.a., and Almo Nature are significant domestic competitors, leveraging local brand recognition, regional supply chain advantages, and connections with professional communities. This competitive landscape fosters innovation while favoring companies that can support strong clinical claims and ensure reliable product availability.

Strategic developments in 2026 highlight the evolving competition within the Italy pet veterinary diets market. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.) introduced k/d + Derm Complete and k/d + z/d Hydrolyzed in June 2026, advancing a multi-condition nutrition model for pets with overlapping renal, dermatological, and gastrointestinal needs. The Purina Institute published research on microbiome and antimicrobial stewardship in May 2026, reinforcing Nestle S.A. (Purina)’s focus on clinical credibility rather than solely relying on brand scale. These initiatives demonstrate that leading companies are prioritizing scientific advancements, broadening indications, and strengthening clinician engagement over mere shelf presence.

Supply-side dynamics are also shaping the Italy pet veterinary diets market, particularly for formulations that incorporate vitamins, omega-3 fatty acids, and microbiome-supporting ingredients. Italy-based manufacturers are strengthening their competitive position through clinical collaborations and the international expansion of their therapeutic nutrition portfolios. Opportunities remain in the mid-market segment between premium global brands and private-label alternatives, particularly for manufacturers that can combine regulatory compliance, scientific evidence, and competitive pricing for long-term therapeutic use.

Italy Pet Veterinary Diets Industry Leaders

  1. Mars Incorporated

  2. Nestle S.A. (Purina)

  3. Farmina Pet Food

  4. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)

  5. Monge & C.s.p.a.

  6. *Disclaimer: Major Players sorted in no particular order
Italy Pet Veterinary Diets Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • June 2026: Colgate-Palmolive Company (Hill's Pet Nutrition Inc.) launched Prescription Diet k/d + Derm Complete and k/d + z/d Hydrolyzed, the first dual-indication therapeutic dry food products in its European portfolio, including Italy. These products address simultaneous renal phosphorus restriction and hydrolyzed protein management for dermatological or GI conditions, reflecting a clinical trend toward nutrition for comorbidities in aging cats.
  • May 2026: Monge and C.s.p.a. launched VetSolution AN-HYDRO, combining a single protein source with XOS prebiotics, live Limosilactobacillus reuteri, and inactivated postbiotics, validated through clinical trials at the University of Teramo with digestibility scores of up to 99% and a probiotic viability shelf life of 18 months.
  • January 2026: Dechra Pharmaceuticals PLC launched SPECIFIC Kidney Support Hydrolysed (FKD-HY and CKD-HY) therapeutic diets across Europe, including Italy, addressing the hydrolyzed-protein sub-segment of renal nutrition.

Table of Contents for Italy Pet Veterinary Diets Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study
  • 1.3 Research Methodology

2. REPORT OFFERS

3. EXECUTIVE SUMMARY & KEY FINDINGS

4. Key Industry Trends

  • 4.1 Pet Population
    • 4.1.1 Cats
    • 4.1.2 Dogs
    • 4.1.3 Other Pets
  • 4.2 Pet Expenditure
  • 4.3 Consumer Trends

5. SUPPLY AND PRODUCTION DYNAMICS

  • 5.1 Trade Analysis
  • 5.2 Ingredient Trends
  • 5.3 Value Chain & Distribution Channel Analysis
  • 5.4 Regulatory Framework
  • 5.5 Market Drivers
    • 5.5.1 Veterinary prescription endorsement of therapeutic diets
    • 5.5.2 Chronic pet disease burden in aging pets
    • 5.5.3 Premiumization of condition-specific nutrition
    • 5.5.4 E-Commerce refill convenience and adherence
    • 5.5.5 Private label veterinary diet alternatives
    • 5.5.6 Preventive nutrition adoption and early intervention
  • 5.6 Market Restraints
    • 5.6.1 Inflation-led down-trading to general maintenance food
    • 5.6.2 Limited veterinary access in rural and southern Italy
    • 5.6.3 Ingredient and label compliance costs
    • 5.6.4 Custom compounding as a substitute in urban areas

6. MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)

  • 6.1 By Sub Product
    • 6.1.1 Diabetes
    • 6.1.2 Digestive Sensitivity
    • 6.1.3 Oral Care Diets
    • 6.1.4 Renal
    • 6.1.5 Urinary Tract Disease
    • 6.1.6 Obesity Diets
    • 6.1.7 Derma Diets
    • 6.1.8 Other Veterinary Diets
  • 6.2 By Pets
    • 6.2.1 Cats
    • 6.2.2 Dogs
    • 6.2.3 Other Pets
  • 6.3 By Distribution Channel
    • 6.3.1 Convenience Stores
    • 6.3.2 Online Channel
    • 6.3.3 Specialty Stores
    • 6.3.4 Supermarkets/Hypermarkets
    • 6.3.5 Other Channels

7. COMPETITIVE LANDSCAPE

  • 7.1 Market Concentration
  • 7.2 Strategic Moves
  • 7.3 Market Share Analysis
  • 7.4 Company Profiles (Includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 7.4.1 Nestle S.A. (Purina)
    • 7.4.2 Mars, Incorporated
    • 7.4.3 Colgate-Palmolive Company (Hill's Pet Nutrition, Inc.)
    • 7.4.4 Farmina Pet Foods
    • 7.4.5 Monge and C. s.p.a.
    • 7.4.6 Affinity Petcare, S.A.
    • 7.4.7 Dechra Pharmaceuticals PLC
    • 7.4.8 Virbac
    • 7.4.9 General Mills, Inc. (Blue Buffalo)
    • 7.4.10 VAFO Praha s.r.o.
    • 7.4.11 United Petfood
    • 7.4.12 Alltech, Inc.
    • 7.4.13 ADM

8. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Italy Pet Veterinary Diets Market Report Scope

Pet veterinary diets (also known as therapeutic or prescription diets) are specialized, scientifically formulated pet foods designed to treat, prevent, or manage specific medical conditions.

The Italy Pet Veterinary Diets Market Report is segmented by sub product (Diabetes, Renal, Urinary Tract Disease, Digestive Sensitivity, Oral Care Diets, Derma Diets, Obesity Diets, and Others), by pets (Cats, Dogs, and Other Pets), and by distribution channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, and others). The market forecasts are provided in terms of value in USD and value in metric tons.

By Sub Product
Diabetes
Digestive Sensitivity
Oral Care Diets
Renal
Urinary Tract Disease
Obesity Diets
Derma Diets
Other Veterinary Diets
By Pets
Cats
Dogs
Other Pets
By Distribution Channel
Convenience Stores
Online Channel
Specialty Stores
Supermarkets/Hypermarkets
Other Channels
By Sub ProductDiabetes
Digestive Sensitivity
Oral Care Diets
Renal
Urinary Tract Disease
Obesity Diets
Derma Diets
Other Veterinary Diets
By PetsCats
Dogs
Other Pets
By Distribution ChannelConvenience Stores
Online Channel
Specialty Stores
Supermarkets/Hypermarkets
Other Channels

Key Questions Answered in the Report

What is the 2026 to 2031 growth outlook for Italy pet veterinary diets?

The Italy pet veterinary diets market is forecast to rise from USD 560 million in 2026 to USD 750 million by 2031 at a 6.0% CAGR.

Which therapeutic category is expanding the fastest in Italy?

Digestive sensitivity is the fastest-growing sub product, with a projected 10.0% CAGR through 2031.

Which pet type generates the most therapeutic diet revenue in Italy?

Dogs are the largest segment, supported by higher spending per patient, longer feeding protocols, and stronger owner compliance.

Which sales channel leads and which one is growing fastest?

Supermarkets/Hypermarkets led with 30.6% of revenue in 2025, while the online channel is growing fastest at a 6.5% CAGR.

Page last updated on: